BUNIA, Democratic Republic of the Congo | November 1, 2026 — More than 5,000 people have died in the Democratic Republic of the Congo’s rapidly expanding Ebola outbreak, with infections also reported in other African countries, raising concerns among health authorities about further cross-border transmission and the growing difficulty of containing the deadly disease.
Figures from the Congolese Ministry of Health reported by the Associated Press on October 31 showed 5,026 deaths among 10,351 infected people, representing a fatality rate of nearly 50 percent. The outbreak, caused by the Bundibugyo strain of Ebola virus, has become the second-deadliest Ebola outbreak recorded, behind the 2014 to 2016 West African epidemic.
The disease has spread to 67 of the country’s 178 health zones across eight of its 26 provinces. The eastern provinces of Ituri and North Kivu remain the hardest hit, accounting for most infections and deaths. According to the Africa Centres for Disease Control and Prevention, approximately 80 percent of new infections are occurring outside the chain of contacts already being monitored, making it difficult for health teams to identify and contain transmission.
The outbreak has also crossed national borders. The US Centers for Disease Control and Prevention reported confirmed cases in the Democratic Republic of the Congo, Kenya, Uganda, Nigeria and France as of October 28. Kenya recorded two deaths, while Uganda also reported two. The latest spread makes this the first documented Ebola outbreak affecting three African regions, according to the Associated Press.
The World Health Organization has warned that the outbreak presents a serious regional public health challenge. The virus spreads through direct contact with the blood and other bodily fluids of infected people, as well as contaminated materials. Symptoms can develop between two and 21 days after exposure, making early detection, isolation and contact tracing essential to preventing further transmission.
Containment efforts have been hampered by armed conflict, population displacement, shortages of medical supplies and growing distrust among affected communities. Eastern Congo has long experienced violence involving armed groups, including the M23 rebel movement and the Allied Democratic Forces, restricting access to some communities and making it dangerous for medical teams to conduct surveillance and treatment.
The response has also been affected by labor disputes. Health workers at some Ebola treatment facilities have staged strikes over months of unpaid wages, while shortages of fuel and financial resources have disrupted services. The Associated Press reported that one-third of recorded deaths occurred outside treatment centers, indicating that many patients died before receiving medical care.
The Bundibugyo strain presents an additional medical challenge because no vaccine or specific treatment has been approved for it. Patients currently receive supportive care to manage symptoms and complications. Clinical trials of potential treatments and investigations into vaccine candidates are underway, according to the WHO.
Ebola was first identified in 1976 following outbreaks in what are now the Democratic Republic of the Congo and South Sudan. The disease takes its name from the Ebola River near the village of Yambuku in the former Zaire, where one of the earliest recognized outbreaks occurred.
The Bundibugyo virus, a distinct Ebola-causing species, was first identified in Uganda in 2007. It subsequently caused an outbreak in the Democratic Republic of the Congo in 2012, but both were far smaller than the current epidemic.
The largest Ebola outbreak in recorded history occurred in West Africa from 2014 to 2016, affecting Guinea, Liberia and Sierra Leone, among other countries, and killing more than 11,000 people. The current outbreak has already surpassed previous Bundibugyo outbreaks in scale and geographic reach.
Health authorities continue to call for stronger disease surveillance, early testing, community cooperation and coordinated action among neighboring countries. The challenge remains not only to treat those infected but also to reach communities where insecurity, limited health services and mistrust are allowing transmission to continue.
Edgardo Hernal started college at UP Diliman and received his BA in Economics from San Sebastian College, Manila, and Masters in Information Systems Management from Keller Graduate School of Management of DeVry University in Oak Brook, IL. He has 25 years of copy editing and management experience at Thomson West, a subsidiary of Thomson Reuters.






